Learning Center

The Principles and Applications of Cell Therapy Biomanufacturing, Characterization, and Regulatory (Feb 12 - April 19, 2024) v.2023-09

The Principles and Applications of Cell Therapy Biomanufacturing, Characterization, and Regulatory (Feb 12 - April 19, 2024) v.2023-09

  • Registration Closed

Developed by field experts from academia, regulatory, clinical, and commercial domains, this program provides a vital training opportunity to develop the fundamental skillset and knowledge unique to CGT manufacturing and to upskill key personnel for roles within companies and clinical manufacturing centres across the Cell & Gene Therapy (CGT) sector. 

Each module includes a series of asynchronous lectures comprised of Theory and Application components as well as a LIVE Expert Panel Discussion and Q&A Session. Participants will receive a certificate of completion upon completion of module assessments.

Key:

Complete
Failed
Available
Locked
MODULE 1: Stem Cell and Immune Cell Engineering and Therapies
Lecture 1.1 Pluripotent and Multipotent Stem Cells
Open to view video.  |  60 minutes
Open to view video.  |  60 minutes Overview, Engineering, Compare & Contrast of Different Types of Cells and their Manufacturing Process THEORY Johnna Temenoff, PhD, Professor, Georgia Tech and Emory University, USA APPLICATION Fabien Moncaubeig, Chief Development Officer, TreeFrog Therapeutics, France
Lecture 1.1 Slide Deck
Open to download resource.
Open to download resource.
Quiz 1.1
10 Questions  |  Unlimited attempts  |  9/11 points to pass
10 Questions  |  Unlimited attempts  |  9/11 points to pass The passing score for this quiz is 80%.
Lecture 1.2 Cellular Reprogramming, Gene Editing, CRISPR
Open to view video.  |  60 minutes
Open to view video.  |  60 minutes THEORY Krishanu Saha, PhD, Associate Professor, University of Wisconsin, USA APPLICATION Robert Deans, PhD, Chief Scientific Officer, Synthego Corp., USA
Lecture 1.2 Slide Deck
Open to download resource.
Open to download resource.
Quiz 1.2
7 Questions  |  Unlimited attempts  |  7/9 points to pass
7 Questions  |  Unlimited attempts  |  7/9 points to pass The passing score for this quiz is 80%.
Lecture 1.3 Immune Cell Engineering, Adoptive Cell Transfer, CAR-T Therapy, and Future of Immune Cell Therapies
Open to view video.  |  60 minutes
Open to view video.  |  60 minutes THEORY Edward Botchwey, PhD, Associate Professor, Georgia Tech, USA APPLICATION David Kugler, PhD, Scientific Director, Engineered T Cell Biology, Bristol Myers Squibb, USA
Lecture 1.3 Slide Deck
Open to download resource.
Open to download resource.
Quiz 1.3
10 Questions  |  Unlimited attempts  |  8/10 points to pass
10 Questions  |  Unlimited attempts  |  8/10 points to pass The passing score for this quiz is 80%.
Module 1 Discussion Board
Make 1 discussion post to continue.
Make 1 discussion post to continue. With course participants from varying backgrounds, experiences, and areas of expertise, there is a unique opportunity for peer-to-peer knowledge sharing and learning. Participation in the discussion boards is strongly encouraged. 1. Post a thought-provoking question related to a topic (or topics) covered in Module 1 that came to mind while viewing the lectures. 2. Respond to a question posted by another participate to share your experience or opinion. 3. Share a publication from within the past 2-3 years relevant to the topic(s) covered in Module 1.
1.4 LIVE Expert Panel Discussion and Q&A Session
02/29/2024 at 11:00 AM (EST)  |  60 minutes
02/29/2024 at 11:00 AM (EST)  |  60 minutes This live-virtual Expert panel discussion Is the opportunity for you to learn from other participants and ask Module 1 speakers questions. You may post your questions in-advanced through the Module 1 discussion board or present your questions through the chat or audio functions in Zoom during the live session. Attendance for all four (4) LIVE Expert Panel & Q&A sessions is mandatory to receive a certificate of course completion. If you are not able to attend, please email Raymond Lam (raymond@isctglobal.org) in advance of the session.
1.4 LIVE Expert Panel Discussion and Q&A Session Recording
Open to view video.
Open to view video.
MODULE 2: Quality Assurance & Regulatory Framework
Lecture 2.1 Quality by Design, Cell Manufacturing Unit Operations, Process Development, Design of Experiments, Critical Quality Attributes (CQAs), and Critical Process Parameters (CPPs)
Open to view video.
Open to view video. THEORY Krishnendu Roy, PhD, Director, NSF Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT), USA APPLICATION Gregory Russotti, PhD, Chief Technology Officer, Century Therapeutics, USA
Lecture 2.1 Slide Deck
Open to download resource.
Open to download resource.
Quiz 2.1
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass The passing score for this quiz is 80%.
Lecture 2.2 Good Manufacturing Practices, Manufacturing Quality Control, Quality Assurance, and Sterility Testing
Open to view video.
Open to view video. THEORY & APPLICATION Donald Singer, Senior Microbiology Technical Consultant, North America, Ecolab, USA
Lecture 2.2 Slide Deck
Open to download resource.
Open to download resource.
Quiz 2.2
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass The passing score for this quiz is 80%.
Lecture 2.3 Ethics & Policy, FDA, Regulatory Issues, Global Regulatory Framework & Key Differences Across the Globe
Open to view video.
Open to view video. THEORY Aaron Levine, PhD, Associate Professor, Georgia Tech, USA APPLICATION Bambi Grilley, RPh, RAC, CIP, CCRC, CCRP, Director, Clinical Research & Early Product Development, Center for Cell & Gene Therapy, Baylor College of Medicine, USA
Lecture 2.3 Slide Deck
Open to download resource.
Open to download resource.
Quiz 2.3
7 Questions  |  Unlimited attempts  |  5/7 points to pass
7 Questions  |  Unlimited attempts  |  5/7 points to pass The passing score for this quiz is 80%.
Module 2 Discussion Board
Make 1 discussion post to continue.
Make 1 discussion post to continue. With course participants from varying backgrounds, experiences, and areas of expertise, there is a unique opportunity for peer-to-peer knowledge sharing and learning. Participation in the discussion boards is strongly encouraged. 1. Post a thought-provoking question related to a topic (or topics) covered in Module 2 that came to mind while viewing the lectures. 2. Respond to a question posted by another participate to share your experience or opinion. 3. Share a publication from within the past 2-3 years relevant to the topic(s) covered in Module 2.
2.4 LIVE Expert Panel Discussion and Q&A Session
03/12/2024 at 12:00 PM (EDT)  |  60 minutes
03/12/2024 at 12:00 PM (EDT)  |  60 minutes This live-virtual Expert panel discussion Is the opportunity for you to learn from other participants and ask Module 2 speakers questions. You may post your questions in-advanced through the Module 2 discussion board or present your questions through the chat or audio functions in Zoom during the live session. Attendance for all four (4) LIVE Expert Panel & Q&A sessions is mandatory to receive a certificate of course completion. If you are not able to attend, please email Raymond Lam (raymond@isctglobal.org) in advance of the session.
2.4 LIVE Expert Panel Discussion and Q&A Session Recording
Open to view video.
Open to view video.
MODULE 2b: Quality Assurance & Regulatory Framework (Optional Asia Focused Content)
Lecture 2.1b (Part 1) Introduction of Quality by Design (QbD) Based Approach Using MSC Manufacturing As an Example
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Shin Kawamata, PhD, MD, CEO, Cyto-Facto Inc. Japan
Lecture 2.1b (part 1) Slide Deck
Open to download resource.
Open to download resource.
Lecture 2.1b (Part 2) QbD-based Manufacturing of iPSC/CAR-T and data Integrity of Cell Products
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Shin Kawamata, PhD, MD, CEO, Cyto-Facto Inc. Japan
Lecture 2.1b (part 2) Slide Deck
Open to download resource.
Open to download resource.
2.2b LIVE Expert Panel Discussion and Q&A Session
03/11/2024 at 9:00 PM (EDT)  |  60 minutes
03/11/2024 at 9:00 PM (EDT)  |  60 minutes This LIVE session provides the opportunity for program participants to ask questions directly to the speakers of Module 2b (Asia Focused). The live discussion is at Tuesday March 12 10AM JST (Monday March 11, 6PM PST) MODERATOR Steve Oh, PhD, Independent Cell Therapy Consultant, Singapore
2.2b LIVE Expert Panel Discussion and Q&A Session Recording
Open to view video.
Open to view video.
Lecture 2.1b Part 1 Quiz
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass The passing score for this quiz is 80%.
Lecture 2.1b Part 2 Quiz
5 Questions  |  Unlimited attempts  |  3/6 points to pass
5 Questions  |  Unlimited attempts  |  3/6 points to pass The passing score for this quiz is 80%.
Module 2b Discussion Board
Make 1 discussion post to continue.
Make 1 discussion post to continue. With course participants from varying backgrounds, experiences, and areas of expertise, there is a unique opportunity for peer-to-peer knowledge sharing and learning. Participation in the discussion boards is strongly encouraged. 1. Post a thought-provoking question related to a topic (or topics) covered in Module 2b that came to mind while viewing the lectures. 2. Respond to a question posted by another participate to share your experience or opinion. 3. Share a publication from within the past 2-3 years relevant to the topic(s) covered in Module 2b.
MODULE 3: Cell Bioprocessing & Manufacturing
Lecture 3.1 Concepts in Scalable Bioprocessing of Cells
Open to view video.
Open to view video. Early vs Late State: Aseptic Techniques, Technologies for Therapeutic Cell Expansion, Bioreactor Design Considerations, Media Formulation, Process Development, CMC, and Introducing New Technologies into Workflow THEORY Carolyn Yeago, PhD, Associate Director – Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Tech, USA APPLICATION Eytan Abraham, PhD, Vice-President, Head of Cell Therapy Franchise, Resilience, USA
Lecture 3.1 Slide Deck
Open to download resource.
Open to download resource.
Quiz 3.1
8 Questions  |  Unlimited attempts  |  6/8 points to pass
8 Questions  |  Unlimited attempts  |  6/8 points to pass The passing score for this quiz is 80%.
Lecture 3.2 3D Microcarriers and Biomaterials, Adherent Cell Expansion, Biocompatible Materials and their Selection Criteria
Open to view video.
Open to view video. THEORY Shalu Suri, PhD, Associate Director, NSF ERC Diversity & Inclusion and Engineering Workforce Development, Georgia Tech, USA APPLICATION Jon Rowley, PhD, Founder and Chief Technology Officer, RoosterBio, USA
Lecture 3.2 Slide Deck
Open to download resource.
Open to download resource.
Quiz 3.2
9 Questions  |  Unlimited attempts  |  7/9 points to pass
9 Questions  |  Unlimited attempts  |  7/9 points to pass The passing score for this quiz is 80%.
Lecture 3.3 Downstream Processing
Open to view video.
Open to view video. Cryopreservation Techniques, Fill and Finish, Storage and Distribution, and Inventory Management THEORY Allison Hubel, PhD, Director, Technological Leadership Institute, University of Minnesota , USA APPLICATION Sean Werner, PhD, President, Sexton Biotechnologies, USA
Lecture 3.3 Slide Deck
Open to download resource.
Open to download resource.
Quiz 3.3
6 Questions  |  Unlimited attempts  |  4/6 points to pass
6 Questions  |  Unlimited attempts  |  4/6 points to pass The passing score for this quiz is 80%.
Lecture 3.4 Supply Chain Management and Distribution, Optimizing Supply Chain & Refining Distribution Strategy
Open to view video.
Open to view video. THEORY Ben Wang, PhD, Professor and Executive Director, Georgia Tech Manufacturing Institute, USA Kan Wang, PhD, Senior Research Engineer, Georgia Tech Manufacturing Institute, USA Chip White, PhD, Professor, Georgia Tech Manufacturing Institute, USA APPLICATION Chris McClain, MBA, Senior Vice President, Business Development, Be the Match BioTherapies, USA Adrian McKemey, PhD, Managing Director, IQVIA, USA
Lecture 3.4 Slide Deck
Open to download resource.
Open to download resource.
Quiz 3.4
4 Questions  |  Unlimited attempts  |  3/4 points to pass
4 Questions  |  Unlimited attempts  |  3/4 points to pass The passing score for this quiz is 80%.
Module 3 Discussion Board
Make 1 discussion post to continue.
Make 1 discussion post to continue. With course participants from varying backgrounds, experiences, and areas of expertise, there is a unique opportunity for peer-to-peer knowledge sharing and learning. Participation in the discussion boards is strongly encouraged. 1. Post a thought-provoking question related to a topic (or topics) covered in Module 3 that came to mind while viewing the lectures. 2. Respond to a question posted by another participate to share your experience or opinion. 3. Share a publication from within the past 2-3 years relevant to the topic(s) covered in Module 3.
3.5 LIVE Expert Panel Discussion and Q&A Session
03/28/2024 at 12:00 PM (EDT)  |  60 minutes
03/28/2024 at 12:00 PM (EDT)  |  60 minutes This live-virtual Expert panel discussion is the opportunity for you to learn from other participants and ask Module 3 speakers questions. You may post your questions in-advanced through the module 3 discussion board or present your questions through the chat or audio functions in Zoom during the live session. Attendance for all four (4) LIVE Expert Panel & Q&A sessions is mandatory to receive a certificate of course completion. If you are not able to attend, please email Raymond Lam (raymond@isctglobal.org) in advance of the session.
3.5 LIVE Expert Panel Discussion and Q&A Session Recording
Open to view video.
Open to view video.
MODULE 4: Cell Product Characterization & Importance of Standards
Lecture 4.1 Analytical Tools in Cell Manufacturing for Quantitative Assessment of CQAs to Ensure Safety and Efficacy
Open to view video.
Open to view video. Identifying Assays and their Principles for Cell Characterization THEORY Carolyn Yeago, PhD, Associate Director – Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Tech, USA APPLICATION Kara Levine, PhD, Head of Systems and Tools, Cell Therapy Bioprocessing, MilliporeSigma, USA
Lecture 4.1 Slide Deck
Open to download resource.
Open to download resource.
Quiz 4.1
8 Questions  |  Unlimited attempts  |  7/9 points to pass
8 Questions  |  Unlimited attempts  |  7/9 points to pass The passing score for this quiz is 80%.
Lecture 4.2 Automation for Cell Manufacturing, Data Management, and Machine Learning for Predictive Analysis
Open to view video.
Open to view video. THEORY Stephen Balakirsky, PhD, Principal Research Scientist, Georgia Tech Research Institute, USA APPLICATION Ian Johnston, PhD, Senior Project Manager Research and Development, Miltenyi Biotec, Germany
Lecture 4.2 Slide Deck
Open to download resource.
Open to download resource.
Quiz 4.2
7 Questions  |  Unlimited attempts  |  8/10 points to pass
7 Questions  |  Unlimited attempts  |  8/10 points to pass The passing score for this quiz is 80%.
Module 4 Discussion Board
Make 1 discussion post to continue.
Make 1 discussion post to continue. With course participants from varying backgrounds, experiences, and areas of expertise, there is a unique opportunity for peer-to-peer knowledge sharing and learning. Participation in the discussion boards is strongly encouraged. 1. Post a thought-provoking question related to a topic (or topics) covered in Module 4 that came to mind while viewing the lectures. 2. Respond to a question posted by another participate to share your experience or opinion. 3. Share a publication from within the past 2-3 years relevant to the topic(s) covered in Module 4.
4.3 LIVE Expert Panel Discussion and Q&A Session
04/09/2024 at 12:00 PM (EDT)  |  60 minutes
04/09/2024 at 12:00 PM (EDT)  |  60 minutes This live-virtual Expert panel discussion is the opportunity for you to learn from other participants and ask Module 4 speakers questions. You may post your questions in-advanced through the Module 4 discussion board or present your questions through the chat or audio functions in Zoom during the live session. Attendance for all four (4) LIVE Expert Panel & Q&A sessions is mandatory to receive a certificate of course completion. If you are not able to attend, please email Raymond Lam (raymond@isctglobal.org) in advance of the session.
4.3 LIVE Expert Panel Discussion and Q&A Session Recording
Open to view video.
Open to view video.
Course Evaluation Form
13 Questions
Course Completion Certificate
No credits available  |  Certificate available
No credits available  |  Certificate available Participants MUST complete all modules, session quizzes and course evaluation form to receive the Course Completion Certificate.